Article
Prognostic implication of an energy metabolism‐related 11‐gene signature in lung cancer
19 Jul 2022
Abstract excerpt
Energy metabolism therapy has gradually shown its potential in the treatment of tumor patients, but it has significant selectivity, thus distinguishing energy subtypes of lung adenocarcinoma (LUAD) is necessary to identify patients who may benefit from energy metabolism interference therapy. Gene expression data downloaded from The Cancer Genome Atlas and Gene Expression Omnibus, molecular subtypes were selected...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
